{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:04:28Z","timestamp":1784837068854,"version":"3.55.0"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The talent revitalization and training funds from Zhejiang Cancer Hospital"},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY16H160039"],"award-info":[{"award-number":["LY16H160039"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Triple-negative breast cancer (TNBC), lacking expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), has clinical features that include high invasiveness, limited response to current immunotherapies, heightened risk of recurrence, and poorer overall prognosis. Central to these adverse clinical outcomes is the tumor microenvironment (TME), where the presence of immature natural killer (NK) cells with lower cytotoxic capacity has been associated with disease progression. Through a comprehensive analysis of publicly available single-cell transcriptomic data from breast cancer, we identified three NK cell subtypes within TNBC and non-TNBC tissues, named NK_XCL1, NK_FCGR3A, and NK_ISG15. Compared to non-TNBC, the presence and cytotoxic activity of NK_FCGR3A cells in TNBC were markedly diminished, primarily due to a substantial increase in the expression of inhibitory receptors like NKG2A (KLRC1). NK_ISG15 cells in TNBC show higher expression of type I interferon signaling genes.\u00a0Through cell-type cross-talk analysis, we found that the feature of NK_FCGR3A cells in TNBC was mediated by myeloid cells with the HLA-E-KLRC1\/HLA-E-CD94:NKG2A signal pathway. Notably, through integrating with public cancer transcriptomic data, we found higher expression of ISG15 is associated with poor prognosis, while higher expression of NK_FCGR3A signature genes is correlated with favorable prognosis. Collectively, these findings and the markers identified offer valuable insights into the mechanisms of immune evasion in TNBC, underscoring potential targets for developing therapeutic strategies that may improve patient outcomes.<\/jats:p>","DOI":"10.1371\/journal.pone.0354524","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:15:24Z","timestamp":1784834124000},"page":"e0354524","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell transcriptomic analysis reveals the immunosuppressive status of NK cell subpopulations in TNBC"],"prefix":"10.1371","volume":"21","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ming","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6967-2167","authenticated-orcid":true,"given":"Weizhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"3","key":"pone.0354524.ref001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"H Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"pone.0354524.ref002","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","DOI":"10.3322\/caac.21654"},{"issue":"3","key":"pone.0354524.ref003","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast Cancer Treatment: A Review","volume":"321","author":"AG Waks","year":"2019","journal-title":"JAMA"},{"issue":"20","key":"pone.0354524.ref004","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"WD Foulkes","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0354524.ref005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41389-025-00549-2","article-title":"Tumor cell-derived ISG15 promotes fibroblast recruitment in oral squamous cell carcinoma via CD11a-dependent glycolytic reprogramming","volume":"14","author":"S-H Wang","year":"2025","journal-title":"Oncogenesis"},{"issue":"10257","key":"pone.0354524.ref006","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(20)31953-X","article-title":"Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial","volume":"396","author":"EA Mittendorf","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"pone.0354524.ref007","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for Early Triple-Negative Breast Cancer","volume":"382","author":"P Schmid","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"pone.0354524.ref008","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41422-020-0355-0","article-title":"A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling","volume":"30","author":"J Qian","year":"2020","journal-title":"Cell Res"},{"issue":"9","key":"pone.0354524.ref009","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","article-title":"A single-cell and spatially resolved atlas of human breast cancers","volume":"53","author":"SZ Wu","year":"2021","journal-title":"Nat Genet"},{"issue":"5","key":"pone.0354524.ref010","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","article-title":"A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer","volume":"27","author":"A Bassez","year":"2021","journal-title":"Nat Med"},{"issue":"686","key":"pone.0354524.ref011","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abl4414","article-title":"Immature natural killer cells promote progression of triple-negative breast cancer","volume":"15","author":"G Thacker","year":"2023","journal-title":"Sci Transl Med"},{"key":"pone.0354524.ref012","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1479-5876-6-25","article-title":"Correlation between NK function and response to trastuzumab in metastatic breast cancer patients","volume":"6","author":"A Beano","year":"2008","journal-title":"J Transl Med"},{"issue":"12","key":"pone.0354524.ref013","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.ccell.2021.09.010","article-title":"Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer","volume":"39","author":"Y Zhang","year":"2021","journal-title":"Cancer Cell"},{"issue":"5","key":"pone.0354524.ref014","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control","volume":"172","author":"JP B\u00f6ttcher","year":"2018","journal-title":"Cell"},{"key":"pone.0354524.ref015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1479-5876-11-145","article-title":"Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients","volume":"11","author":"ML Ascierto","year":"2013","journal-title":"J Transl Med"},{"key":"pone.0354524.ref016","doi-asserted-by":"crossref","first-page":"1200282","DOI":"10.3389\/fimmu.2023.1200282","article-title":"Natural killer cell-related prognostic risk model predicts prognosis and treatment outcomes in triple-negative breast cancer","volume":"14","author":"Z Liu","year":"2023","journal-title":"Front Immunol"},{"issue":"9","key":"pone.0354524.ref017","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1172\/JCI45816","article-title":"Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity","volume":"121","author":"E Mamessier","year":"2011","journal-title":"J Clin Invest"},{"issue":"1","key":"pone.0354524.ref018","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","article-title":"Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression","volume":"20","author":"C Hafemeister","year":"2019","journal-title":"Genome Biol"},{"issue":"1","key":"pone.0354524.ref019","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1038\/s41598-019-41695-z","article-title":"From Louvain to Leiden: guaranteeing well-connected communities","volume":"9","author":"VA Traag","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"pone.0354524.ref020","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"G Yu","year":"2012","journal-title":"OMICS"},{"issue":"4","key":"pone.0354524.ref021","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","article-title":"CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes","volume":"15","author":"M Efremova","year":"2020","journal-title":"Nat Protoc"},{"issue":"1","key":"pone.0354524.ref022","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12864-018-4772-0","article-title":"Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics","volume":"19","author":"K Street","year":"2018","journal-title":"BMC Genomics"},{"issue":"4","key":"pone.0354524.ref023","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells","volume":"32","author":"C Trapnell","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"11","key":"pone.0354524.ref024","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nmeth.4463","article-title":"SCENIC: single-cell regulatory network inference and clustering","volume":"14","author":"S Aibar","year":"2017","journal-title":"Nat Methods"},{"issue":"11","key":"pone.0354524.ref025","article-title":"A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast","volume":"40","author":"B Pal","year":"2021","journal-title":"EMBO J"},{"issue":"6","key":"pone.0354524.ref026","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41587-025-02743-4","article-title":"Shortcomings of silhouette in single-cell integration benchmarking","volume":"44","author":"P Rautenstrauch","year":"2026","journal-title":"Nat Biotechnol"},{"issue":"1","key":"pone.0354524.ref027","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/s41467-021-22300-2","article-title":"Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling","volume":"12","author":"Q Hu","year":"2021","journal-title":"Nat Commun"},{"issue":"3","key":"pone.0354524.ref028","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cell.2010.03.040","article-title":"NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways","volume":"141","author":"J Cui","year":"2010","journal-title":"Cell"},{"issue":"6","key":"pone.0354524.ref029","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.cell.2020.02.029","article-title":"SnapShot: Natural Killer Cells","volume":"180","author":"A Crinier","year":"2020","journal-title":"Cell"},{"issue":"5","key":"pone.0354524.ref030","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","article-title":"Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment","volume":"174","author":"E Azizi","year":"2018","journal-title":"Cell"},{"issue":"1","key":"pone.0354524.ref031","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12943-020-01238-x","article-title":"Natural killer cells in cancer biology and therapy","volume":"19","author":"S-Y Wu","year":"2020","journal-title":"Mol Cancer"},{"issue":"43","key":"pone.0354524.ref032","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"A Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pone.0354524.ref033","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc.2015.5","article-title":"NK cells and cancer: you can teach innate cells new tricks","volume":"16","author":"MG Morvan","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"pone.0354524.ref034","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1158\/2159-8290.CD-20-0655","article-title":"Tumor-Infiltrating Natural Killer Cells","volume":"11","author":"B C\u00f3zar","year":"2021","journal-title":"Cancer Discov"},{"key":"pone.0354524.ref035","doi-asserted-by":"crossref","first-page":"5618786","DOI":"10.1155\/2020\/5618786","article-title":"Inflammation Is Associated with Worse Outcome in the Whole Cohort but with Better Outcome in Triple-Negative Subtype of Breast Cancer Patients","volume":"2020","author":"M Oshi","year":"2020","journal-title":"J Immunol Res"},{"issue":"8","key":"pone.0354524.ref036","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2694","article-title":"Signal integration by JNK and p38 MAPK pathways in cancer development","volume":"9","author":"EF Wagner","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"pone.0354524.ref037","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1016\/j.cell.2023.07.034","article-title":"A pan-cancer single-cell panorama of human natural killer cells","volume":"186","author":"F Tang","year":"2023","journal-title":"Cell"},{"key":"pone.0354524.ref038","doi-asserted-by":"crossref","first-page":"960852","DOI":"10.3389\/fimmu.2022.960852","article-title":"Implications of NKG2A in immunity and immune-mediated diseases","volume":"13","author":"X Wang","year":"2022","journal-title":"Front Immunol"},{"issue":"7403","key":"pone.0354524.ref039","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"C Curtis","year":"2012","journal-title":"Nature"},{"issue":"1","key":"pone.0354524.ref040","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12943-022-01672-z","article-title":"NK cells and solid tumors: therapeutic potential and persisting obstacles","volume":"21","author":"L Tong","year":"2022","journal-title":"Mol Cancer"},{"issue":"8000","key":"pone.0354524.ref041","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41586-023-06945-1","article-title":"Natural killer cell therapies","volume":"626","author":"E Vivier","year":"2024","journal-title":"Nature"},{"key":"pone.0354524.ref042","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1479-5876-8-71","article-title":"First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity","volume":"8","author":"C Brignone","year":"2010","journal-title":"J Transl Med"},{"key":"pone.0354524.ref043","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3389\/fimmu.2020.01242","article-title":"Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis","volume":"11","author":"S Zhang","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"pone.0354524.ref044","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1158\/2159-8290.CD-23-0519","article-title":"NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer","volume":"14","author":"BC Taylor","year":"2024","journal-title":"Cancer Discov"},{"issue":"11","key":"pone.0354524.ref045","doi-asserted-by":"crossref","first-page":"9521","DOI":"10.3390\/ijms24119521","article-title":"NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic Potential","volume":"24","author":"F Portale","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"pone.0354524.ref046","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","article-title":"Exploring the NK cell platform for cancer immunotherapy","volume":"18","author":"JA Myers","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"pone.0354524.ref047","doi-asserted-by":"crossref","first-page":"15081","DOI":"10.1038\/ncomms15081","article-title":"Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer","volume":"8","author":"W Chung","year":"2017","journal-title":"Nat Commun"},{"issue":"9","key":"pone.0354524.ref048","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1200\/JCO.2014.58.1967","article-title":"Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers","volume":"33","author":"C Denkert","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"pone.0354524.ref049","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"C Denkert","year":"2018","journal-title":"Lancet Oncol"},{"issue":"9","key":"pone.0354524.ref050","doi-asserted-by":"crossref","first-page":"113216","DOI":"10.1016\/j.isci.2025.113216","article-title":"Differentiation-associated ISG expression of NK cells in chronic viral infection","volume":"28","author":"F Keller","year":"2025","journal-title":"iScience"},{"issue":"8","key":"pone.0354524.ref051","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41590-020-0728-z","article-title":"The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies","volume":"21","author":"T Bald","year":"2020","journal-title":"Nat Immunol"},{"issue":"8","key":"pone.0354524.ref052","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","article-title":"A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments","volume":"24","author":"KC Barry","year":"2018","journal-title":"Nat Med"},{"issue":"6","key":"pone.0354524.ref053","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1089\/jir.2016.0103","article-title":"Beyond ISGlylation: Functions of Free Intracellular and Extracellular ISG15","volume":"37","author":"PF Dos Santos","year":"2017","journal-title":"J Interferon Cytokine Res"},{"issue":"12","key":"pone.0354524.ref054","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1052935","article-title":"ISG15: A double edged sword in cancer","volume":"4","author":"SD Desai","year":"2015","journal-title":"Oncoimmunology"},{"issue":"2","key":"pone.0354524.ref055","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1158\/2326-6066.CIR-18-0085","article-title":"CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer-Draining Lymph Nodes","volume":"7","author":"A Frazao","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"pone.0354524.ref056","doi-asserted-by":"crossref","first-page":"1231916","DOI":"10.3389\/fimmu.2023.1231916","article-title":"KLRC1 knockout overcomes HLA-E-mediated inhibition and improves NK cell antitumor activity against solid tumors","volume":"14","author":"A Mac Donald","year":"2023","journal-title":"Front Immunol"},{"issue":"5","key":"pone.0354524.ref057","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1172\/JCI123955","article-title":"Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells","volume":"129","author":"T Kamiya","year":"2019","journal-title":"J Clin Invest"},{"issue":"10","key":"pone.0354524.ref058","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI0215564","article-title":"IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94\/NKG2A-dependent mechanism","volume":"110","author":"K-J Malmberg","year":"2002","journal-title":"J Clin Invest"},{"key":"pone.0354524.ref059","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-immunol-101921-044122","article-title":"Designing Cancer Immunotherapies That Engage T Cells and NK Cells","volume":"41","author":"O Kyrysyuk","year":"2023","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"pone.0354524.ref060","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-019-0052-1","article-title":"NK cells for cancer immunotherapy","volume":"19","author":"N Shimasaki","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"pone.0354524.ref061","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.4049\/jimmunol.1002629","article-title":"HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients","volume":"185","author":"EM de Kruijf","year":"2010","journal-title":"J Immunol"},{"issue":"29","key":"pone.0354524.ref062","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1200\/JCO.22.00227","article-title":"COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer","volume":"40","author":"RS Herbst","year":"2022","journal-title":"J Clin Oncol"},{"issue":"7","key":"pone.0354524.ref063","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells","volume":"175","author":"P Andr\u00e9","year":"2018","journal-title":"Cell"},{"key":"pone.0354524.ref064","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1200\/JCO.2018.36.15_suppl.3540","article-title":"First-in-human dose escalation of monalizumab plus durvalumab, with expansion in patients with metastatic microsatellite-stable colorectal cancer","volume":"36","author":"NH Segal","year":"2018","journal-title":"JCO"},{"key":"pone.0354524.ref065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.breast.2023.06.007","article-title":"Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer: Results of the MIMOSA trial","volume":"70","author":"VCM Geurts","year":"2023","journal-title":"Breast"},{"issue":"4","key":"pone.0354524.ref066","article-title":"A Hiplot-based web service for cold atmospheric plasma high-throughput data integration and analysis on breast cancer","volume":"4","author":"X Dai","year":"2025","journal-title":"Imeta"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354524","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:15:42Z","timestamp":1784834142000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354524"}},"subtitle":[],"editor":[{"given":"UDAYAN","family":"BHATTACHARYA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":66,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0354524","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}